Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma

British Journal of Haematology

Volumn 95, Issue 2, 1996, Pages 349-353

  Govindarajan, Rangaswamy ^a   Jagannath, Sundar ^a   Flick, James T ^a   Vesole, David H ^a   Sawyer, Jeffrey ^a   Barlogie, Bart ^a   Tricot, Guido ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Alkylating agents; Autologous transplantation; High dose chemotherapy; Multiple myeloma; Myelodysplastic syndromes

Indexed keywords

ALKYLATING AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; MELPHALAN; PREDNISONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

EID: 0029804411     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1891.x     Document Type: Article

References (23)

1. Armitage, J., Vose, J., Anderson, J., Bierman, P., Bishop, M. & Kessinger, A. (1993) Complete remission following high-dose chemotherapy and autologous hematopoietic rescue for non-Hodgkin's lymphoma. Journal of Clinical Oncology. 12, 36 3a.
2. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of myelodysplastic syndromes. British Journal of Haematology, 51, 189 199.
3. Branch, D.R., Gallagher, M.T., Forman, S.J., Winkler, K.J., Retz, L.D. & Blume, K.G. (1982) Endogenous stem cell repopulation resulting in mixed hematopoietic chimerism following total body irradiation and marrow transplantation for acute leukemia. Transplantation. 34, 226-228.
4. Chao, N.J., Nademanee, A.P., Long, G.D., Schmidt, G.M., Doulon, T.A., Parker, P., Slovak, M.L., Nagasawa, L.S., Blume, K.G. & Forman, S.J. (1991) Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease, Journal of Clinical Oncology. 9, 1575-1579.
5. Chen, H., Sandler, D.P., Taylor, J.A., Shore, D.L., Liu, E., Bloomfield, C.D. & Bell, D.A. (1996) Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect, Lancet. 347, 295-297.
6. Darrington, D.L., Vose, J.M., Anderson, J.R., Bierman, P.J., Bishop, M.R., Chan, W.C., Morris, M.E., Reed, E.C., Sanger, W.G., Tarantolo, S.R., Weisenberger, D.D., Kessinger, A. & Armitage, J.O. (1994) Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy autologous stem-cell transplantation for lymphoid malignancies. Journal of Clinical Oncology. 12, 2527-2534.
7. Greene, M.H., Young, R.C., Merril, J.M. & DeVita, V.T. (1983) Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy for non-Hodgkin's lymphoma. Cancer Research. 43, 1891-1898.
8. Kaldor, J.M., Day, N.E., Clarke, E.A., Van Leeuwen, F.E., HenryAmar, M., Fiorentino, M.V., Bell, J., Pederson, D., Band, P., Assouline, D., Koch, M., Choi, W., Prior, P., Blair, V., Langmark, F., Kirn, V.P., Cuzick, J., Sutcliffe, S.B., Somers, R., Pellae-Cossett, B., Pappalagallo, G.L., Fraser, P., Storm, H. & Stovall, M. (1990) Leukemia following Hodgkin's disease. New England Journal of Medicine, 322, 7-13.
9. Levine, E.G. & Bloomfield, C.D. (1992) Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Seminars in Oncology, 19, 47-84.
10. Marsh, J.C.W. & Geary, C.G. (1991) Is aplastic anaemia a preleukaemic disorder? British Journal of Haematology, 77, 447-452.
11. Miller, J.S., Arthur, D.C., Litz, C.E., Neglia, J.P., Miller, W.J. & Weisdorf, D.J. (1994) Myelodysplastic syndrome after autologous bone marrow transplantation: an additional complication of curative cancer therapy. Blood. 12, 3780-3786.
12. Mitelman, F. (ed.) (1991) ISCN 1991, Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. S. Karger, Basel.
13. Pederson-Bjergaard, J., Ersboll, J., Sorensen, M.H., Keiding, N., Larsen, S.O., Philip, P., Larsen, M.S., Schultz, H. & Nissen, N.I. (1985) Risk of nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Annals of Internal Medicine, 103, 195-200.
14. Pederson-Bjergaard, J., Specht, L., Larsen, S.D., Ersboll, J., Struck, J., Hansen, M.M., Hansen, H.H. & Nissen, N.I. (1987) Risk of therapy related leukaemia and preleukaemia after Hodgkin's disease. Lancet, ii, 83-88.
15. Petz, L.D. Yam, P., Wallace, R.B., Stock, A.D., DeLange, G., Knowlton, R.G., Brown, V.A., Donis-Keller, H., Hill, L.R., Forman, S.J. & Blume, K.G. (1987) Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies. Blood. 70, 1331-1337.
16. Rohatiner, A.Z.S. (1994) Myelodysplasia and acute myelogenous leukemia after myeloablative therapy with autologous stem-cell transplantation. Journal of Clinical Oncology. 12, 2521-2522.
17. Rohatiner, A.Z.S., Johnson, P.W.M., Price, C.G.A., Arnott, S.J., Arness, J.A.L., Norton, A.J., Dorey, E., Adams, K., Whelan, J.S., Matthews, J., Maccallum, P.K., Oza, A.M. & Lister, T.A. (1994) Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. Journal of Clinical Oncology. 12, 1177-1184.
18. Sawyer, J.R., Waldron, J.A., Jagannath, S. & Barlogie, B. (1995) Cytogenelic findings in 200 patients with multiple myeloma. Cancer Genetics and Cytogenetics, 82, 41-49.
19. Shulman, N.L. (1993) Therapy related second malignancies. Hematology/Oncology Clinics of North America, 7, 325-335.
20. Stone, R.M., Neuberg, D., Soiffer, R., Takvorian, T., Whelan, M., Rabinow, S.N., Astler, J.C., Leavitt, P., Mauch, P., Freedman, A.S. & Nadler, L.M. (1994) Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. Journal of Clinical Oncology, 12, 2535-2542.
21. Traweek, S.T., Slowak, M.L., Nademanee, A.P., Brynes, R.K., Niland, J.C. & Forman, S.J. (1992) Myelodysplasia occurring after autologous bone marrow transplantation (ABMT) for Hodgkin's disease and non-Hodgkin's lymphoma. Blood. 80, (Suppl. 1), 455a.
22. Tricot, G., Jagannath, S., Vesole, D., Nelson, J., Tindle, S., Miller, L., Cheson, B., Crowley, J. & Barlogie, B. (1995) Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood. 85, 588-596.
23. Tucker, M.A., Meadows, A.T., Boise, J.D., Jr. Stovall, M., Obealin, O., Stone, B.J., Bisch, J., Voute, P.A., Hoover, R.N. & Fraumein, J.F., Jr (1987) Leukemia after therapy with alkylating agents for childhood cancer. Journal of the National Cancer Institute. 78, 459-464.